This inventor holds 1 USPTO granted patent. Top assignee: University of Pennsylvania. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Raffael Nachbagauer and mRNA Vaccine Innovation
Introduction
Raffael Nachbagauer is an inventor associated with New York, NY, and the University of Pennsylvania. His work includes a patent titled “Universal Influenza Vaccine Using Nucleoside-Modified mRNA.”
Latest Patents
The provided information lists one patent for Nachbagauer: “Universal Influenza Vaccine Using Nucleoside-Modified mRNA.” The invention concerns the use of nucleoside-modified messenger RNA in developing a universal influenza vaccine. 1 patent
Career Highlights
Nachbagauer’s listed patent connects his inventive work with vaccine research at the University of Pennsylvania. The available details do not specify his role or the patent’s filing and grant dates.
Collaborations
The provided information names Norbert Pardi and Drew Weissman as Nachbagauer’s coworkers. Their shared institutional connection reflects a research environment focused on mRNA and vaccine innovation.
Conclusion
Raffael Nachbagauer’s listed patent highlights his contribution to research into nucleoside-modified mRNA and universal influenza vaccine development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile